Therapeutic potential of neutralizing antibodies in the treatment of HIV-1 infection

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 4, 2003, Pages 757-759

  Stiegler, Gabriela ^a   Katinger, Hermann ^a  

^a UNIVERSITY OF AGRICULTURAL SCIENCES   (Austria)

Author keywords

HIV; Neutralizing antibodies

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD4 IMMUNOGLOBULIN G2; ENFUVIRTIDE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; HUMAN MONOCLONAL ANTIBODY; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN SUBCLASS; MONOCLONAL ANTIBODY 2F5; MONOCLONAL ANTIBODY 2G1; MONOCLONAL ANTIBODY 2G12; MONOCLONAL ANTIBODY 4E10; MONOCLONAL ANTIBODY IGG1B1; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MACACA; NONHUMAN; PASSIVE IMMUNIZATION; SIDE EFFECT; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS DNA CELL DNA INTERACTION; VIRUS LOAD; VIRUS REPLICATION;

ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CLINICAL TRIALS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNIZATION, PASSIVE;

EID: 0037394318     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg172     Document Type: Article

References (19)

1. Stiehm, E. R., Mofenson, L., Zolla-Pazner, S., Jackson, B., Martin, N. L. & Ammann, A. J. (1995). Summary of the workshop on passive immunotherapy in the prevention and treatment of HIV infection. The Passive Antibody Workshop Participants. Clinical Immunology and Immunopathology 75, 84-93.
2. Kilby, J. M., Hopkins, S., Venetta, T. M., DiMassimo, B., Cloud, G. A., Lee, J. Y. et al. (1998). Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nature Medicine 4, 1302-7.
3. Buchacher, A., Predl, R., Strutzenberger, K., Steinfellner, W., Trkola, A., Purtscher, M. et al. (1994). Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. AIDS Research and Human Retroviruses 10, 359-69.
4. Trkola, A., Purtscher, M., Muster, T., Ballaun, C., Buchacher, A., Sullivan, N. et al. (1996). Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glyco-protein of human immunodeficiency virus type 1. Journal of Virology 70, 1100-8.
5. Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P. W. et al. (1994). Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266, 1024-7.
6. Purtscher, M., Trkola, A., Gruber, G., Buchacher, A., Predl, R., Steindl, F. et al. (1994). A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Research and Human Retroviruses 10, 1651-8.
7. Stiegler, G., Kunert, R., Purtscher, M., Wolbank, S., Voglauer, R., Steindl, F. et al. (2001). A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. AIDS Research and Human Retro-viruses 17, 1757-65.
8. Trkola, A., Pomales, A. B., Yuan, H., Korber, B., Maddon, P. J., Allaway, G. et al. (1995). Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. Journal of Virology 69, 6609-17.
9. Stiegler, G., Armbruster, C., Vcelar, B., Stoiber, H., Kunert, R., Michael, N. L. et al. (2002). Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans: a phase I evaluation. AIDS 16, 2019-25.
10. Mascola, J. R., Lewis, M. G., Stiegler, G., Harris, D., VanCott, T. C., Hayes, D. et al. (1999). Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. Journal of Virology 73, 4009-18.
11. Mascola, J. R., Stiegler, G., VanCott, T. C., Katinger, H., Carpenter, C. B., Hanson, C. E. et al. (2000). Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nature Medicine 6, 207-10.
12. Cavacini, L. A., Samore, M. H., Gambertoglio, J., Jackson, B., Duval, M., Wisnewski, A. et al. (1998). Phase I study of a human monoclonal antibody directed against the CD4-binding site of HIV type 1 glycoprotein 120. AIDS Research and Human Retroviruses 14, 545-50.
13. Baba, T. W., Liska, V., Hofmann-Lehmann, R., Vlasak, J., Xu, W., Ayehunie, S. et al. (2000). Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nature Medicine 6, 200-6.
14. Hofmann-Lehmann, R., Vlasak, J., Rasmussen, R. A., Jiang, S., Li, P. L., Baba, T. W. et al. (2002). Postnatal pre- and post-exposure passive immunization strategies: protection of neonatal macaques against oral simian-human immunodeficiency virus challenge. Journal of Medical Primatology 31, 109-19.
15. Pilgrim, A. K., Pantaleo, G., Cohen, O. J., Fink, L. M., Zhou, J. Y., Zhou, J. T. et al. (1997). Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. Journal of Infectious Diseases 176, 924-32.
16. Cecilia, D., Kleeberger, C., Munoz, A., Giorgi, J. V. & Zolla-Pazner, S. (1999). A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects. Journal of Infectious Diseases 179, 1365-74.
17. Jacobson, J. M., Lowy, I., Fletcher, C. V., O'Neill, T. J., Tran, D. N., Ketas, T. et al. (2000). Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults. Journal of Infectious Diseases 182, 326-9.
18. Armbruster, C., Stiegler, G. M., Vcelar, B. A., Jäger, W., Michael, N. L., Vetter, N. et al. (2002). A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1. AIDS 16, 227-33.
19. Xu, W., Smith-Franklin, B. A., Li, P. L., Wood, C., He, J., Du, Q. et al. (2001). Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade B. Journal of Human Virology 4, 55-61.